Drug Profile
Vorsetuzumab mafodotin
Alternative Names: SGN-75Latest Information Update: 18 Dec 2023
Price :
$50
*
At a glance
- Originator Seattle Genetics
- Class Antineoplastics; Auristatins; Drug conjugates; Immunotoxins; Monoclonal antibodies
- Mechanism of Action Apoptosis stimulants; Mitosis inhibitors; Tubulin inhibitors; Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma; Renal cancer